WHO ICTRP trial
A clinical trial of tumor markers in the clinical application of urothelial…
ChiCTR-DDD-17012810 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-DDD-17012810 |
|---|---|
| Public title | A clinical trial of tumor markers in the clinical application of urothelial carcinoma |
| Scientific title | A clinical trial of tumor markers in the clinical application of urothelial carcinoma |
| Primary sponsor | Lanzhou University Second Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Diagnostic test |
| Phase | Diagnostic New Technique Clincal Study |
| Countries | China |
| Conditions | Urothelial Carcinoma |
| Interventions | Gold Standard:The clinical diagnostic criteria were based on the results of cases;Index test:BTA(magnetic particle chemiluminescence method), NMP22(magnetic particle chemiluminescence method), MMP-9 (magnetic particle chemiluminescence… |
| Registration date | Sep 26, 2017 |
| Target size | Target condition:2128;Difficult condition:1470 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: